Development of myasthenia gravis during treatment of chronic hepatitis C with interferon-alpha and ribavirin

Journal of Gastroenterology

Volumn 36, Issue 10, 2001, Pages 723-724

  Weegink, Christine J ^a   Chamuleau, Robert A F M ^a   Reesink, Henk W ^a   Molenaar, Delmar S M ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA2B INTERFERON; ANTIBODY; CHOLINERGIC RECEPTOR; LEVOTHYROXINE; PREDNISOLONE; PYRIDOSTIGMINE; RIBAVIRIN; THYROID ANTIBODY; VIRUS RNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARM; ARTIFICIAL VENTILATION; CASE REPORT; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DIPLOPIA; DYSPHAGIA; ELECTROMYOGRAPHY; HASHIMOTO DISEASE; HEPATITIS C; HEPATITIS C VIRUS; HOSPITAL ADMISSION; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; LEG; LETTER; LIVER BIOPSY; MALE; MONOTHERAPY; MYALGIA; MYASTHENIA GRAVIS; PRIORITY JOURNAL;

ADULT; ANTIVIRAL AGENTS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; MALE; MYASTHENIA GRAVIS; RIBAVIRIN;

EID: 0034757082     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005350170038     Document Type: Letter

References (6)

1. Myasthenia gravis: Another autoimmune disease associated with hepatitis C virus infection
2. Side effects of alpha interferon in chronic hepatitis C
3. Ribavirin treatment for patients with chronic hepatitis C: Results of a placebo-controlled study
4. Myasthenia during interferon alpha therapy
5. Development of myasthenia gravis during interferon-alpha treatment for anti-HCV positive chronic hepatitis
6. Myasthenia gravis in a patient with chronic active hepatitis C during interferon-alpha treatment